Gilead Sciences · 17 hours ago
Exec Director, Global Commercial Product Strategy - Lenacapavir for Prevention
United States - California - Foster City
Full-time
Hybrid
Director/Executive
$281K/yr - $364K/yr
15+ years expGilead Sciences is dedicated to creating a healthier world and is seeking an Executive Director for Global Commercial Product Strategy for Lenacapavir for Prevention. This role involves leading the global commercial vision and execution for an important HIV prevention portfolio, overseeing cross-functional alignment and market development to ensure sustained global growth.
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Lead a cross-geography commercialization strategy and execution team to define and deliver the global commercial vision, ‑long range‑ strategy, and integrated annual plans for the lenacapavir prevention portfolio
Serve as Commercialization Team Leader, enabling decision making‑ across Medical Affairs, Clinical Development, Value & Access, Public Affairs, Government Affairs, Regulatory, Legal, and Insights partners
Lead the development of the Indication Strategic Plan (ISP) and Global Plan of Action (GPOA), ensuring clear linkage to regional and country HIV prevention plans
Lead, coach, and develop a high performing global team, fostering a culture of inclusion, accountability, collaboration, and innovation‑
Manage and shape external partnerships, agency relationships, and global marketing investments
Build strong and trusted partnerships with Gilead’s priority (G9) and emerging markets to ensure global strategies are actionable, scalable, and tailored to local needs
Collaborate closely with Value & Access to shape pricing, access, and reimbursement strategies across diverse healthcare, prevention, and policy environments
Support global guidelines, policy, and ecosystem shaping efforts to expand access to long-acting‑ HIV prevention
Integrate global market intelligence, competitive insights, and customer needs into commercial, clinical, access, and evidence generation strategies‑
Identify and translate market, customer, and ecosystem insights into clear business opportunities, strategic priorities, and global commercial plans
Lead global launch readiness and market preparation for the ex‑US rollout of lenacapavir for Prevention, ensuring coordinated preparation across regions
Oversee early commercial planning and readiness activities for future lenacapavir prevention assets as they advance through development
Drive global brand positioning, messaging, and multichannel campaign development to ensure clear differentiation and strong early market‑ establishment
Provide commercial leadership into clinical development, lifecycle planning, evidence generation, and publication strategy to support future label, payer, and customer needs
Contribute to long‑range planning, scenario planning, asset valuation, and enterprise strategy discussions
Develop executive level‑ materials for Earnings Calls, LE guidance, long range‑ plan (LRP), governance forums, and strategic reviews
Represent Global Commercial Strategy in enterprise initiatives related to HIV, prevention, long-acting platforms, and access expansion
Qualification
Required
15+ years of biopharmaceutical commercial experience, including extensive global or regional strategy leadership
Proven experience leading cross functional teams and influencing senior executive levels
Experience working within or across multiple key markets
Demonstrated success in global launch planning, market development, or brand strategy for specialty or prevention focused therapeutics
Strong strategic thinking, analytical skills, and ability to translate insights into actionable strategies
Excellent leadership, communication, and stakeholder management capabilities
Preferred
HIV, infectious disease, or prevention ecosystem experience
Consumer/Direct to Consumer experience
Prior responsibility for evidence strategy, lifecycle planning, or shaping policy/market access environments
Benefits
Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans
Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
10001+ employees
H1B Sponsorship
Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)
Funding
Current Stage
Public CompanyTotal Funding
$4.41BKey Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B
Leadership Team
Keeley Wettan
Senior Vice President, Legal
Patrick Loerch
Senior Vice President, Clinical Data Science
Recent News
2026-01-23
GlobeNewswire
2026-01-22
Company data provided by crunchbase